Home

Headache

Read time: 3 min

Congress highlights

Real world study casts new light on potential of polypharmacy

The fact that 20-25% of patients with schizophrenia are treated with more than one antipsychotic1...

Read time: 2 min

Congress highlights

Addressing the unmet need of cognitive dysfunction in schizophrenia

Metacognition needs to be an important component of cognitive remediation therapy (CRT) to...

Read time: 2 min

Congress highlights

Key priorities for Mental Health policies beyond 2020

Being a voice, sharing knowledge and reaching the whole of society are key priorities for EPA in...

Read time: 2 min

Congress highlights

The sooner the better: Early detection and intervention in psychosis

Early detection and intervention services for patients with psychosis are at different stages of...

Read time: 4 min

Congress highlights

CGRP – new perspectives in headache management

Three new takes on the potential for calcitonin gene-related proteins were presented at this year...

Read time: 4 min

Congress highlights

Exploring new avenues for monitoring and treating cluster headache

Treatment options for cluster headache have remained static for years. At EHF 2020, a scientific...

Read time: 2 min

Congress highlights

How to address patient concerns about neuromodulation in migraine

Neuromodulation is a possible alternative to medications for treatment of migraine, but many...

Read time: 2 min

Why do antidepressants cause emotional blunting and what can be done to resolve it in clinical practice?

Emotional blunting describes an indifferent, unresponsive affect and inability to feel emotions...

Are relapse prevention and functioning sufficiently prioritized in the treatment of schizophrenia?

Read the full article here.

Are relapse prevention and functioning sufficiently prioritized in the treatment of schizophrenia?

Read time: 3 min

Congress highlights

Fine-tuning psychiatric diagnosis to guide treatment and prognosis

Syndromal psychiatric diagnoses are based on guidance provided by the International Classification...

From response and remission to full functional recovery in major depressive disorder: Is patient-involvement the missing link?

Read the full article here.

From response and remission to full functional recovery in major depressive disorder: Is patient-involvement the missing link?

Professor McIntyre discusses the difference in perspectives between doctors and patients with major depressive disorder

Professor McIntyre highlights how the concerns of doctors differ from those of patients with major...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country